Find clinical trials for Colon Cancer in Madrid, MD
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Colon Cancer trials near Madrid, MD, ESP:
." . The aim is to see if this new approach can show early signs of effectiveness in treating participants with a specific type of colon cancer...
Phase 2
Madrid, Spain and 11 other locations
(SOC) in participants with untreated T4N0 or Stage III (resectable), defective mismatch repair/ microsatellite instability high (dMMR/MSI-H) colon...
Phase 3
Madrid, Spain and 249 other locations
The purpose of this study is to measure tumor response to treatment with ompenaclid (RGX-202-01) in patients with previously treated RAS mut...
Phase 2
Madrid, Spain and 27 other locations
and pembrolizumab) given together for the treatment of colorectal cancer that:* is metastatic (spread to other parts of the body);* has the ...
Phase 2
Madrid, Madrid, Comunidad DE, Spain and 65 other locations
as a second-line method for the detection of both colorectal cancer and advanced adenomas when used prospectively in the screening populatio...
Madrid, Spain and 1 other location
dehydrogenase 1 (IDH1) arginine 132 (R132)-mutant advanced solid tumors, including but not limited to cholangiocarcinoma, chondrosarcoma, an...
Phase 1
Madrid, Spain and 32 other locations
This is an open-label, first-in-human study designed to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor ...
Phase 1, Phase 2
Madrid, Spain and 85 other locations
The goal of this low-risk interventional study is to analyze participants' assessment of colorectal cancer screening program through screeni...
Madrid, Madrid, Spain and 1 other location
to participants with locally advanced or metastatic solid tumors with certain KRAS mutations. LY4066434 will be given alone or in combinatio...
Phase 1
Madrid, Spain and 57 other locations
This study is to evaluate the safety, tolerability, and PK profiles of RMC-6291 and RMC-6236 in adults with KRAS G12C-mutated solid tumors....
Phase 1
Madrid, Spain and 53 other locations
Clinical trials
Research sites
Resources
Legal